Medical Ikkou Group Co.,Ltd.
Medical Ikkou Group Co.,Ltd. (3353.T) Stock Overview
Explore Medical Ikkou Group Co.,Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
9.7B
P/E Ratio
9.30
EPS (TTM)
$301.28
ROE
0.08%
3353.T Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Medical Ikkou Group Co.,Ltd. (3353.T) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 69.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2121.61.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.30 and a market capitalization of 9.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Medical Ikkou Group Co.,Ltd. operates dispensing pharmacies in Japan. The company is also involved in the operation of nursing homes, outpatient nursing care facilities, and home-visit nursing care facilities; wholesale of generic drugs; and rental of real estate properties, as well as invests in listed and unlisted stocks, M&A, etc. It operates 93 dispensing pharmacy stores. The company was founded in 1980 and is headquartered in Tsu, Japan.
Toshihisa Minamino
1,431
No. 36-25, Nishimarunouchi, Tsu
2004